Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Novavax to participate in Oxford Com-COV3 study » 19:04
09/16/21
09/16
19:04
09/16/21
19:04
NVAX

Novavax

$237.14 /

+5.03 (+2.17%)

Novavax announced its…

Novavax announced its participation in a newly expanded Phase 2 clinical trial called Comparing COVID-19 Vaccine Schedule Combinations - Stage 3, led by the University of Oxford and funded by the UK Vaccines Taskforce and the National Institute for Health Research. Novavax' recombinant nanoparticle COVID-19 vaccine candidate, NVX-CoV2373, is one of the three COVID-19 vaccines that will be studied in adolescents to evaluate the potential for combined regimens that mix vaccines from different manufacturers to achieve immune protection against COVID-19. "Expanding our understanding of how different COVID-19 vaccines can be used to implement flexible vaccine programs across all age groups will be vital to ultimately controlling the pandemic," said Gregory M. Glenn, M.D., President of Research and Development, Novavax. "A mixed vaccination series could offer the potential to maximize the use of existing vaccine supply, increase the total number of individuals who can ultimately be vaccinated and accelerate rapid and equitable access across the globe." Com-COV3 will include at least 360 adolescents 12-16 years of age. Volunteers will receive an authorized vaccine as a first dose and then at least 8 weeks later will receive one of three different vaccines as a second dose. All participants will be randomly allocated at the time of the second dose to receive either a full dose or half dose of the same vaccine given for the first dose, a full dose of the Novavax vaccine or a half dose of a different authorized vaccine. The research will compare the immune system responses from those who receive a heterologous regimen to those who receive a homologous regimen.

ShowHide Related Items >><<
NVAX Novavax
$237.14 /

+5.03 (+2.17%)

NVAX Novavax
$237.14 /

+5.03 (+2.17%)

09/08/21 Cantor Fitzgerald
Novavax combo vaccine could have 'differentiating' value, says Cantor Fitzgerald
08/30/21 B. Riley
Novavax is leader in making Covid-flu combination candidate, says B. Riley
08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
NVAX Novavax
$237.14 /

+5.03 (+2.17%)

NVAX Novavax
$237.14 /

+5.03 (+2.17%)

NVAX Novavax
$237.14 /

+5.03 (+2.17%)

NVAX Novavax
$237.14 /

+5.03 (+2.17%)

Over a week ago
Hot Stocks
Novavax continues slide after Covid vaccine update at Citi conference » 11:21
09/10/21
09/10
11:21
09/10/21
11:21
NVAX

Novavax

$247.98 /

-10.96 (-4.23%)

Shares of Novavax are…

Shares of Novavax are down $11.48, or 4%, to $247.29 in morning trading after the stock also declined yesterday following the company having provided an update for investors at Citi's 16th Annual BioPharma Conference, presenting information relating to NVX-CoV2373, the company's coronavirus vaccine candidate. In slides for the event outlining its "key upcoming milestones," Novavax said it expects to complete regulatory filings for emergency authorization with the MHRA, WHO, EMA, FDA, New Zealand Medsafe, Health Canada and Australian Therapeutic Goods Administration by the "end of 2021." It also expects to reach anticipated manufacturing capacity of 150M doses per month, begin "expansive distribution of NVX-CoV2373" by the end of the year, the presentation slides stated. Reference Link

ShowHide Related Items >><<
NVAX Novavax
$247.98 /

-10.96 (-4.23%)

NVAX Novavax
$247.98 /

-10.96 (-4.23%)

09/08/21 Cantor Fitzgerald
Novavax combo vaccine could have 'differentiating' value, says Cantor Fitzgerald
08/30/21 B. Riley
Novavax is leader in making Covid-flu combination candidate, says B. Riley
08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
NVAX Novavax
$247.98 /

-10.96 (-4.23%)

NVAX Novavax
$247.98 /

-10.96 (-4.23%)

NVAX Novavax
$247.98 /

-10.96 (-4.23%)

NVAX Novavax
$247.98 /

-10.96 (-4.23%)

Recommendations
Novavax combo vaccine could have 'differentiating' value, says Cantor Fitzgerald » 13:39
09/08/21
09/08
13:39
09/08/21
13:39
NVAX

Novavax

$270.03 /

-0.37 (-0.14%)

After Novavax announced…

After Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate a combination vaccine using Novavax' seasonal influenza and COVID-19 vaccines, Cantor Fitzgerald analyst Charles Duncan commented that the combo vaccine "may result in differentiating pharmacoeconomic value for high-risk elderlies." However, he adds that in his view "the key event" remains the acceptance of EUAs and BLAs for NVX-CoV2373 and although he continues to see there being value in diversifying technology for vaccines, he wonders why '2373 "appears to have not yet made visible progress with regulators." Duncan maintains an Overweight rating with a $272 price target on Novavax shares.

ShowHide Related Items >><<
NVAX Novavax
$270.03 /

-0.37 (-0.14%)

NVAX Novavax
$270.03 /

-0.37 (-0.14%)

08/30/21 B. Riley
Novavax is leader in making Covid-flu combination candidate, says B. Riley
08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
NVAX Novavax
$270.03 /

-0.37 (-0.14%)

NVAX Novavax
$270.03 /

-0.37 (-0.14%)

NVAX Novavax
$270.03 /

-0.37 (-0.14%)

NVAX Novavax
$270.03 /

-0.37 (-0.14%)

Hot Stocks
Novavax initiates Phase 1/2 clinical trial combining influenza, COVID-19 vaccine » 08:24
09/08/21
09/08
08:24
09/08/21
08:24
NVAX

Novavax

$270.40 /

+18.91 (+7.52%)

Novavax announced…

Novavax announced enrollment of the first participants in a Phase 1/2 study to evaluate the safety and immunogenicity of a combination vaccine using Novavax' seasonal influenza and COVID-19 vaccines. The clinical trial combines Novavax' recombinant protein-based NVX-CoV2373 and NanoFlu vaccine candidates and patented saponin-based Matrix-M adjuvant in a single formulation. Both NVX-CoV2373 and NanoFlu have previously demonstrated strong results as standalone vaccines in Phase 3 clinical trials. "This study is the first-of-its-kind to evaluate the vaccine's potential to induce a robust immune response, augmented by our Matrix-M adjuvant, against two life-threatening diseases simultaneously," said Gregory M. Glenn, M.D., President of Research and Development, Novavax. "The combination of these two vaccines, which have individually delivered outstanding results with favorable safety and tolerability profiles, may lead to greater efficiencies for the healthcare system and achieve high levels of protection against COVID-19 and influenza with a single regimen." The trial will evaluate the safety, tolerability and immune response to NanoFlu formulated together with NVX-CoV2373 and Matrix-M adjuvant in 640 healthy adults 50 to 70 years of age. Participants will have been either previously infected with the SARS-CoV-2 virus that causes COVID-19 or vaccinated through an authorized vaccine at least eight weeks prior to enrollment. All participants will be randomly assigned to cohorts to evaluate multiple formulations and will be dosed on Day 0 and again at Day 56. The trial will be conducted in Australia at up to 12 study sites, with results expected during the first half of 2022.

ShowHide Related Items >><<
NVAX Novavax
$270.40 /

+18.91 (+7.52%)

NVAX Novavax
$270.40 /

+18.91 (+7.52%)

08/30/21 B. Riley
Novavax is leader in making Covid-flu combination candidate, says B. Riley
08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
NVAX Novavax
$270.40 /

+18.91 (+7.52%)

NVAX Novavax
$270.40 /

+18.91 (+7.52%)

NVAX Novavax
$270.40 /

+18.91 (+7.52%)

NVAX Novavax
$270.40 /

+18.91 (+7.52%)

Options
Novavax call volume above normal and directionally bullish » 11:45
09/07/21
09/07
11:45
09/07/21
11:45
NVAX

Novavax

$265.67 /

+14.18 (+5.64%)

Bullish option flow…

Bullish option flow detected in Novavax with 27,657 calls trading, 1.4x expected, and implied vol increasing almost 4 points to 77.27%. 9/10 weekly 300 calls and 9/10 weekly 270 calls are the most active options, with total volume in those strikes near 4,900 contracts. The Put/Call Ratio is 0.37. Earnings are expected on November 8th.

ShowHide Related Items >><<
NVAX Novavax
$265.67 /

+14.18 (+5.64%)

NVAX Novavax
$265.67 /

+14.18 (+5.64%)

08/30/21 B. Riley
Novavax is leader in making Covid-flu combination candidate, says B. Riley
08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
NVAX Novavax
$265.67 /

+14.18 (+5.64%)

NVAX Novavax
$265.67 /

+14.18 (+5.64%)

NVAX Novavax
$265.67 /

+14.18 (+5.64%)

NVAX Novavax
$265.67 /

+14.18 (+5.64%)

Hot Stocks
Novavax 'commends' CDC for continued support of COVID-19 trial volunteers » 16:11
08/30/21
08/30
16:11
08/30/21
16:11
NVAX

Novavax

$233.41 /

+6.64 (+2.93%)

Novavax announced that…

Novavax announced that the U.S. Centers for Disease Control and Prevention has provided updated guidance for those who have been vaccinated as part of a clinical trial in the U.S. The CDC guidance states that participants in the Novavax PREVENT-19 Phase 3 clinical trial meet the criteria to be considered fully vaccinated two weeks after they have completed the vaccine series. "Novavax commends the CDC for its continued support for COVID-19 clinical trial volunteers, with this update providing clarity and guidance for participants in our PREVENT-19 Phase 3 clinical trial," said Gregory Glenn, M.D., President of Research and Development, Novavax. "We are grateful to all of our clinical trial participants who have helped create a safer future for all."

ShowHide Related Items >><<
NVAX Novavax
$233.41 /

+6.64 (+2.93%)

NVAX Novavax
$233.41 /

+6.64 (+2.93%)

08/30/21 B. Riley
Novavax is leader in making Covid-flu combination candidate, says B. Riley
08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
NVAX Novavax
$233.41 /

+6.64 (+2.93%)

NVAX Novavax
$233.41 /

+6.64 (+2.93%)

NVAX Novavax
$233.41 /

+6.64 (+2.93%)

NVAX Novavax
$233.41 /

+6.64 (+2.93%)

Recommendations
Novavax is leader in making Covid-flu combination candidate, says B. Riley » 07:18
08/30/21
08/30
07:18
08/30/21
07:18
NVAX

Novavax

$226.66 /

-3.53 (-1.53%)

B. Riley analyst Mayank…

B. Riley analyst Mayank Mamtani reiterates a Buy rating on Novavax with a $305 price target. The analyst sees a "cloud of uncertainty" on the broader Covid-19 vaccine landscape, particularly as it relates to widespread use of boosters in order to curb the delta variant. Mamtani remains encouraged by the role Novavax has to play in driving increased penetration among the unvaccinated segments within the U.S. and globally, given NVX-CoV2373's "safety advantage" relative to the mRNAs vaccines. Novavax's adjuvanted subunit protein platform allows for rapid generation of multi-valent vaccines, as already demonstrated by success noted with late-stage development of NanoFlu, which should guide company's "industry-leading efforts" for developing a Covid-flu combination candidate, says the analyst.

ShowHide Related Items >><<
NVAX Novavax
$226.66 /

-3.53 (-1.53%)

NVAX Novavax
$226.66 /

-3.53 (-1.53%)

08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
NVAX Novavax
$226.66 /

-3.53 (-1.53%)

NVAX Novavax
$226.66 /

-3.53 (-1.53%)

NVAX Novavax
$226.66 /

-3.53 (-1.53%)

NVAX Novavax
$226.66 /

-3.53 (-1.53%)

On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:46
08/25/21
08/25
16:46
08/25/21
16:46
JNJ

Johnson & Johnson

$174.21 /

-1.14 (-0.65%)

, SAVA

Cassava Sciences

$80.84 /

-36.78 (-31.27%)

, PBTS

Powerbridge

$1.34 /

-0.05 (-3.60%)

, TAK

Takeda Pharmaceutical

$16.82 /

-0.05 (-0.30%)

, MRNA

Moderna

$397.57 /

+2.61 (+0.66%)

, CCL

Carnival

$24.11 /

+0.27 (+1.13%)

, TBPH

Theravance Biopharma

$8.70 /

-0.525 (-5.69%)

, MDT

Medtronic

$134.57 /

+1.95 (+1.47%)

, BYND

Beyond Meat

$122.28 /

-1.85 (-1.49%)

, RCII

Rent-A-Center

$64.76 /

-0.24 (-0.37%)

, PNM

PNM Resources

$49.59 /

+0.02 (+0.04%)

, AGR

Avangrid

$53.91 /

+0.03 (+0.06%)

, GS

Goldman Sachs

$413.00 /

+4.44 (+1.09%)

, KSS

Kohl's

$60.13 /

-0.06 (-0.10%)

, TSM

TSMC

$117.03 /

+4.92 (+4.39%)

, DDAIF

Daimler AG

$83.56 /

+0.36 (+0.43%)

, ARGGY

Aston Martin Lagonda

$27.35 /

+ (+0.00%)

, WDC

Western Digital

$65.50 /

+4.73 (+7.78%)

, NVAX

Novavax

$238.17 /

+5.025 (+2.16%)

, AFRM

Affirm

$72.75 /

+4.15 (+6.05%)

, HOOD

Robinhood

$48.94 /

-0.41 (-0.83%)

, QIWI

Qiwi

$9.06 /

-0.585 (-6.07%)

, DKS

Dick's Sporting

$129.61 /

+15.29 (+13.37%)

, JWN

Nordstrom

$31.14 /

-6.72 (-17.75%)

, TOL

Toll Brothers

$63.63 /

+2.42 (+3.95%)

, EXPR

Express

$6.44 /

-0.835 (-11.49%)

, URBN

Urban Outfitters

$36.86 /

-3.82 (-9.39%)

Get caught up quickly on…

ShowHide Related Items >><<
WDC Western Digital
$65.50 /

+4.73 (+7.78%)

URBN Urban Outfitters
$36.86 /

-3.82 (-9.39%)

TSM TSMC
$117.03 /

+4.92 (+4.39%)

TOL Toll Brothers
$63.63 /

+2.42 (+3.95%)

TBPH Theravance Biopharma
$8.70 /

-0.525 (-5.69%)

TAK Takeda Pharmaceutical
$16.82 /

-0.05 (-0.30%)

SAVA Cassava Sciences
$80.84 /

-36.78 (-31.27%)

QIWI Qiwi
$9.06 /

-0.585 (-6.07%)

PNM PNM Resources
$49.59 /

+0.02 (+0.04%)

PBTS Powerbridge
$1.34 /

-0.05 (-3.60%)

NVAX Novavax
$238.17 /

+5.025 (+2.16%)

MRNA Moderna
$397.57 /

+2.61 (+0.66%)

MDT Medtronic
$134.57 /

+1.95 (+1.47%)

KSS Kohl's
$60.13 /

-0.06 (-0.10%)

JWN Nordstrom
$31.14 /

-6.72 (-17.75%)

JNJ Johnson & Johnson
$174.21 /

-1.14 (-0.65%)

HOOD Robinhood
$48.94 /

-0.41 (-0.83%)

GS Goldman Sachs
$413.00 /

+4.44 (+1.09%)

EXPR Express
$6.44 /

-0.835 (-11.49%)

DKS Dick's Sporting
$129.61 /

+15.29 (+13.37%)

DDAIF Daimler AG
$83.56 /

+0.36 (+0.43%)

CCL Carnival
$24.11 /

+0.27 (+1.13%)

BYND Beyond Meat
$122.28 /

-1.85 (-1.49%)

ARGGY Aston Martin Lagonda
$27.35 /

+ (+0.00%)

AGR Avangrid
$53.91 /

+0.03 (+0.06%)

AFRM Affirm
$72.75 /

+4.15 (+6.05%)

JNJ Johnson & Johnson
$174.21 /

-1.14 (-0.65%)

08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
07/29/21 Benchmark
Emergent BioSolutions' catalysts 'falling into place,' says Benchmark
SAVA Cassava Sciences
$80.84 /

-36.78 (-31.27%)

08/25/21 JonesTrading
Cassava addressed most key concerns in lawyer report, says JonesTrading
08/03/21 B. Riley
Cassava Sciences price target raised to $145 from $111 at B. Riley
07/30/21 B. Riley
Cassava Sciences data represents 'home run scenario,' says B. Riley
07/20/21 H.C. Wainwright
Cassava Sciences price target raised to $124 from $97 at H.C. Wainwright
PBTS Powerbridge
$1.34 /

-0.05 (-3.60%)

TAK Takeda Pharmaceutical
$16.82 /

-0.05 (-0.30%)

04/27/21 Chardan
LogicBio collaborations may signal recognition of platforms, says Chardan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
04/19/21 JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
MRNA Moderna
$397.57 /

+2.61 (+0.66%)

08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/06/21
Fly Intel: Top five analyst downgrades
08/06/21 Oppenheimer
Moderna downgraded to Perform from Outperform at Oppenheimer
08/06/21 Piper Sandler
Moderna downgraded to Neutral from Overweight at Piper Sandler
CCL Carnival
$24.11 /

+0.27 (+1.13%)

08/19/21 HSBC
Carnival price target raised to $18.30 from $14.70 at HSBC
08/06/21 Citi
Citi ups Carnival target, sees 'great entry point' after pullback
07/14/21 Berenberg
Carnival plc upgraded to Hold from Sell at Berenberg
07/01/21 Morgan Stanley
Morgan Stanley cuts Carnival estimates 'again' as cruising resumes at slow pace
TBPH Theravance Biopharma
$8.70 /

-0.525 (-5.69%)

08/24/21 Morgan Stanley
Morgan Stanley cuts Theravance Biopharma to Underweight after failed UC study
08/24/21 Morgan Stanley
Theravance downgraded to Underweight from Overweight at Morgan Stanley
08/24/21
Fly Intel: Top five analyst downgrades
08/24/21 SVB Leerink
Theravance Biopharma price target lowered to $29 from $37 at SVB Leerink
MDT Medtronic
$134.57 /

+1.95 (+1.47%)

08/25/21 Truist
Medtronic price target raised to $148 from $138 at Truist
08/25/21 Credit Suisse
Medtronic price target raised to $146 from $137 at Credit Suisse
08/25/21 Wells Fargo
Medtronic price target raised to $151 from $140 at Wells Fargo
08/25/21 Raymond James
Medtronic price target raised to $142 from $135 at Raymond James
BYND Beyond Meat
$122.28 /

-1.85 (-1.49%)

08/25/21
Fly Intel: Top five analyst downgrades
08/25/21 Argus
Beyond Meat downgraded to Hold at Argus on disappointing guidance
08/25/21 Argus
Beyond Meat downgraded to Hold from Buy at Argus
08/06/21 Piper Sandler
Beyond Meat spending will continue to weigh on margins, says Piper Sandler
RCII Rent-A-Center
$64.76 /

-0.24 (-0.37%)

08/25/21
Fly Intel: Top five analyst initiations
08/25/21 BofA
Rent-A-Center started with Buy at BofA on lease-to-own rollout opportunity
08/25/21 BofA
Rent-A-Center initiated with a Buy at BofA
08/12/21 Janney Montgomery Scott
Rent-A-Center upgraded to Buy from Neutral at Janney Montgomery Scott
PNM PNM Resources
$49.59 /

+0.02 (+0.04%)

08/25/21 Argus
PNM Resources downgraded to Hold from Buy at Argus
08/24/21 Mizuho
Avangrid price target raised to $53 from $51 at Mizuho
03/03/21 Citi
PNM Resources downgraded to Neutral from Buy at Citi
01/06/21 Wells Fargo
PNM Resources downgraded to Underweight from Equal Weight at Wells Fargo
AGR Avangrid
$53.91 /

+0.03 (+0.06%)

07/23/21 Mizuho
Avangrid price target lowered to $51 from $52 at Mizuho
05/20/21
Fly Intel: Top five analyst initiations
GS Goldman Sachs
$413.00 /

+4.44 (+1.09%)

07/14/21 Oppenheimer
Goldman Sachs price target raised to $540 from $493 at Oppenheimer
07/14/21 Credit Suisse
Goldman Sachs price target raised to $425 from $420 at Credit Suisse
07/14/21 Mizuho
Affirm selloff on Apple competition fears overblown, says Mizuho
07/14/21 Piper Sandler
Goldman Sachs price target raised to $435 from $420 at Piper Sandler
KSS Kohl's
$60.13 /

-0.06 (-0.10%)

08/20/21 Baird
Kohl's price target raised to $70 from $68 at Baird
08/20/21 Deutsche Bank
Kohl's price target raised to $80 from $73 at Deutsche Bank
08/11/21 Deutsche Bank
Kohl's named Short-Term Catalyst Buy idea at Deutsche Bank
08/09/21 BofA
BofA sees Kohl's partnership with Sephora as key driver to boost sales, earnings
TSM TSMC
$117.03 /

+4.92 (+4.39%)

08/02/21 Needham
Silicon Motion price target raised to $115 from $100 at Needham
07/19/21 Morgan Stanley
Texas Instruments price target raised to $185 from $176 at Morgan Stanley
07/06/21 Citi
Intel outsourcing chips to TSMC will help gain back share, says Citi
06/30/21
Fly Intel: Top five analyst upgrades
DDAIF Daimler AG
$83.56 /

+0.36 (+0.43%)

08/11/21 Barclays
Daimler AG price target lowered to EUR 110 from EUR 115 at Barclays
08/09/21 Jefferies
Daimler AG downgraded to Hold from Buy at Jefferies
08/01/21 Goldman Sachs
Daimler AG upgraded to Conviction Buy from Buy at Goldman Sachs
07/23/21 Kepler Cheuvreux
Daimler AG upgraded to Buy at Kepler Cheuvreux following pullback
ARGGY Aston Martin Lagonda
$27.35 /

+ (+0.00%)

08/02/21 JPMorgan
Aston Martin Lagonda price target raised to 1,700 GBp at JPMorgan
07/07/21 JPMorgan
Aston Martin Lagonda price target raised to 1,430 GBp at JPMorgan
05/11/21 Goldman Sachs
Aston Martin Lagonda upgraded to Neutral from Sell at Goldman Sachs
03/23/21 Kepler Cheuvreux
Autos upgraded to Overweight from Neutral at Kepler Cheuvreux
WDC Western Digital
$65.50 /

+4.73 (+7.78%)

08/25/21 Wells Fargo
Focus to be on accounting in Western Digital, Kioxia deal, says Wells Fargo
08/24/21 Stifel
Seagate, Western Digital research report brings buying opportunity, says Stifel
08/16/21 UBS
Western Digital assumed with a Neutral at UBS
08/13/21 Wedbush
Western Digital, Silicon Motion should be bought on pullback, says Wedbush
NVAX Novavax
$238.17 /

+5.025 (+2.16%)

08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
AFRM Affirm
$72.75 /

+4.15 (+6.05%)

08/25/21 BofA
Affirm price target raised to $82 from $71 at BofA
08/23/21 Oppenheimer
Peloton price target lowered to $140 from $150 at Oppenheimer
08/18/21 Truist
Truist starts Marqeta at Buy on next-gen vCard solutions success
08/03/21 DA Davidson
Affirm downgraded to Neutral from Buy at DA Davidson
HOOD Robinhood
$48.94 /

-0.41 (-0.83%)

08/23/21
Fly Intel: Top five analyst initiations
08/23/21 Rosenblatt
Robinhood initiated with a Buy at Rosenblatt
08/23/21 JPMorgan
JPMorgan starts Robinhood at Underweight, says success priced into shares
08/23/21 Deutsche Bank
Deutsche starts Robinhood at Hold despite 'exceptionally attractive' potential
QIWI Qiwi
$9.06 /

-0.585 (-6.07%)

08/25/21 JPMorgan
Qiwi loses Russia betting contract but factored into outlook, says JPMorgan
08/25/21 JPMorgan
Qiwi loses Russian betting contract to competitor, says JPMorgan
04/13/21
Qiwi upgraded to Hold from Sell at Sberbank CIB
12/11/20 Goldman Sachs
Qiwi downgraded to Neutral from Buy at Goldman Sachs
DKS Dick's Sporting
$129.61 /

+15.29 (+13.37%)

08/20/21 Cowen
Dick's Sporting price target raised to $150 from $147 at Cowen
08/18/21 Wedbush
Dick's Sporting price target raised to $125 from $110 at Wedbush
08/11/21
Fly Intel: Top five analyst initiations
08/11/21 Wells Fargo
Dick's Sporting resumed with an Equal Weight at Wells Fargo
JWN Nordstrom
$31.14 /

-6.72 (-17.75%)

08/25/21 Credit Suisse
Nordstrom price target lowered to $34 from $39 at Credit Suisse
08/25/21 JPMorgan
JPMorgan downgrades Nordstrom to sell on 'underwhelming' performance
08/25/21 JPMorgan
Nordstrom downgraded to Underweight from Neutral at JPMorgan
08/25/21 Deutsche Bank
Nordstrom price target lowered to $37 from $40 at Deutsche Bank
TOL Toll Brothers
$63.63 /

+2.42 (+3.95%)

06/30/21 Goldman Sachs
Toll Brothers price target lowered to $55 from $59 at Goldman Sachs
06/28/21 BTIG
Toll Brothers upgraded to Neutral from Sell at BTIG
05/27/21 BTIG
Toll Brothers price target raised to $59 from $49 at BTIG
05/27/21 Barclays
Toll Brothers price target raised to $62 from $53 at Barclays
EXPR Express
$6.44 /

-0.835 (-11.49%)

06/04/21 B. Riley
Express price target raised to $4.50 from $3.50 at B. Riley
03/11/21 B. Riley
Express price target raised to $3.50 from $1.50 at B. Riley Securities
01/15/21 B. Riley
Express price target raised to $1.50 from $1 at B. Riley Securities
URBN Urban Outfitters
$36.86 /

-3.82 (-9.39%)

08/25/21 BMO Capital
Urban Outfitters price target raised to $37 from $35 at BMO Capital
08/25/21 MKM Partners
Urban Outfitters price target raised to $43 from $41 at MKM Partners
08/25/21 Wells Fargo
Urban Outfitters price target raised to $40 from $35 at Wells Fargo
08/25/21 Deutsche Bank
Urban Outfitters price target raised to $42 from $40 at Deutsche Bank
WDC Western Digital
$65.50 /

+4.73 (+7.78%)

URBN Urban Outfitters
$36.86 /

-3.82 (-9.39%)

TSM TSMC
$117.03 /

+4.92 (+4.39%)

TOL Toll Brothers
$63.63 /

+2.42 (+3.95%)

TBPH Theravance Biopharma
$8.70 /

-0.525 (-5.69%)

TAK Takeda Pharmaceutical
$16.82 /

-0.05 (-0.30%)

SAVA Cassava Sciences
$80.84 /

-36.78 (-31.27%)

RCII Rent-A-Center
$64.76 /

-0.24 (-0.37%)

QIWI Qiwi
$9.06 /

-0.585 (-6.07%)

PNM PNM Resources
$49.59 /

+0.02 (+0.04%)

NVAX Novavax
$238.17 /

+5.025 (+2.16%)

MRNA Moderna
$397.57 /

+2.61 (+0.66%)

MDT Medtronic
$134.57 /

+1.95 (+1.47%)

KSS Kohl's
$60.13 /

-0.06 (-0.10%)

JWN Nordstrom
$31.14 /

-6.72 (-17.75%)

JNJ Johnson & Johnson
$174.21 /

-1.14 (-0.65%)

HOOD Robinhood
$48.94 /

-0.41 (-0.83%)

GS Goldman Sachs
$413.00 /

+4.44 (+1.09%)

EXPR Express
$6.44 /

-0.835 (-11.49%)

DKS Dick's Sporting
$129.61 /

+15.29 (+13.37%)

DDAIF Daimler AG
$83.56 /

+0.36 (+0.43%)

CCL Carnival
$24.11 /

+0.27 (+1.13%)

BYND Beyond Meat
$122.28 /

-1.85 (-1.49%)

AGR Avangrid
$53.91 /

+0.03 (+0.06%)

AFRM Affirm
$72.75 /

+4.15 (+6.05%)

  • 29
    Jul
  • 25
    Jun
  • 23
    Feb
  • 13
    Jan
  • 13
    Nov
WDC Western Digital
$65.50 /

+4.73 (+7.78%)

TSM TSMC
$117.03 /

+4.92 (+4.39%)

TOL Toll Brothers
$63.63 /

+2.42 (+3.95%)

TAK Takeda Pharmaceutical
$16.82 /

-0.05 (-0.30%)

SAVA Cassava Sciences
$80.84 /

-36.78 (-31.27%)

NVAX Novavax
$238.17 /

+5.025 (+2.16%)

MRNA Moderna
$397.57 /

+2.61 (+0.66%)

MDT Medtronic
$134.57 /

+1.95 (+1.47%)

KSS Kohl's
$60.13 /

-0.06 (-0.10%)

JNJ Johnson & Johnson
$174.21 /

-1.14 (-0.65%)

HOOD Robinhood
$48.94 /

-0.41 (-0.83%)

GS Goldman Sachs
$413.00 /

+4.44 (+1.09%)

EXPR Express
$6.44 /

-0.835 (-11.49%)

DDAIF Daimler AG
$83.56 /

+0.36 (+0.43%)

CCL Carnival
$24.11 /

+0.27 (+1.13%)

BYND Beyond Meat
$122.28 /

-1.85 (-1.49%)

ARGGY Aston Martin Lagonda
$27.35 /

+ (+0.00%)

AFRM Affirm
$72.75 /

+4.15 (+6.05%)

WDC Western Digital
$65.50 /

+4.73 (+7.78%)

TSM TSMC
$117.03 /

+4.92 (+4.39%)

TOL Toll Brothers
$63.63 /

+2.42 (+3.95%)

TBPH Theravance Biopharma
$8.70 /

-0.525 (-5.69%)

TAK Takeda Pharmaceutical
$16.82 /

-0.05 (-0.30%)

SAVA Cassava Sciences
$80.84 /

-36.78 (-31.27%)

RCII Rent-A-Center
$64.76 /

-0.24 (-0.37%)

QIWI Qiwi
$9.06 /

-0.585 (-6.07%)

PNM PNM Resources
$49.59 /

+0.02 (+0.04%)

PBTS Powerbridge
$1.34 /

-0.05 (-3.60%)

MRNA Moderna
$397.57 /

+2.61 (+0.66%)

KSS Kohl's
$60.13 /

-0.06 (-0.10%)

JNJ Johnson & Johnson
$174.21 /

-1.14 (-0.65%)

HOOD Robinhood
$48.94 /

-0.41 (-0.83%)

GS Goldman Sachs
$413.00 /

+4.44 (+1.09%)

EXPR Express
$6.44 /

-0.835 (-11.49%)

DKS Dick's Sporting
$129.61 /

+15.29 (+13.37%)

DDAIF Daimler AG
$83.56 /

+0.36 (+0.43%)

CCL Carnival
$24.11 /

+0.27 (+1.13%)

BYND Beyond Meat
$122.28 /

-1.85 (-1.49%)

AFRM Affirm
$72.75 /

+4.15 (+6.05%)

WDC Western Digital
$65.50 /

+4.73 (+7.78%)

URBN Urban Outfitters
$36.86 /

-3.82 (-9.39%)

TSM TSMC
$117.03 /

+4.92 (+4.39%)

TOL Toll Brothers
$63.63 /

+2.42 (+3.95%)

TAK Takeda Pharmaceutical
$16.82 /

-0.05 (-0.30%)

SAVA Cassava Sciences
$80.84 /

-36.78 (-31.27%)

QIWI Qiwi
$9.06 /

-0.585 (-6.07%)

NVAX Novavax
$238.17 /

+5.025 (+2.16%)

MRNA Moderna
$397.57 /

+2.61 (+0.66%)

MDT Medtronic
$134.57 /

+1.95 (+1.47%)

KSS Kohl's
$60.13 /

-0.06 (-0.10%)

JWN Nordstrom
$31.14 /

-6.72 (-17.75%)

JNJ Johnson & Johnson
$174.21 /

-1.14 (-0.65%)

HOOD Robinhood
$48.94 /

-0.41 (-0.83%)

GS Goldman Sachs
$413.00 /

+4.44 (+1.09%)

EXPR Express
$6.44 /

-0.835 (-11.49%)

DKS Dick's Sporting
$129.61 /

+15.29 (+13.37%)

CCL Carnival
$24.11 /

+0.27 (+1.13%)

BYND Beyond Meat
$122.28 /

-1.85 (-1.49%)

AFRM Affirm
$72.75 /

+4.15 (+6.05%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:16
08/25/21
08/25
12:16
08/25/21
12:16
JNJ

Johnson & Johnson

$174.47 /

-0.88 (-0.50%)

, SAVA

Cassava Sciences

$89.11 /

-28.51 (-24.24%)

, PBTS

Powerbridge

$1.39 /

-0.005 (-0.36%)

, AMCX

AMC Networks

$47.88 /

-0.63 (-1.30%)

, DAL

Delta Air Lines

$41.39 /

+0.87 (+2.15%)

, TBPH

Theravance Biopharma

$8.49 /

-0.73 (-7.92%)

, MDT

Medtronic

$134.55 /

+1.93 (+1.46%)

, BYND

Beyond Meat

$121.25 /

-2.88 (-2.32%)

, RCII

Rent-A-Center

$65.54 /

+0.54 (+0.83%)

, CPB

Campbell Soup

$41.05 /

-0.98 (-2.33%)

, GS

Goldman Sachs

$416.31 /

+7.75 (+1.90%)

, KSS

Kohl's

$60.17 /

-0.02 (-0.03%)

, AMZN

Amazon.com

$3,292.98 /

-14.14 (-0.43%)

, TSM

TSMC

$118.14 /

+6.03 (+5.38%)

, DDAIF

Daimler AG

$83.20 /

+1.065 (+1.30%)

, ARGGY

Aston Martin Lagonda

$27.35 /

+0.7 (+2.63%)

, APO

Apollo Global

$58.55 /

+0.915 (+1.59%)

, NVAX

Novavax

$240.57 /

+7.425 (+3.18%)

, MRNA

Moderna

$401.40 /

+6.44 (+1.63%)

, AFRM

Affirm

$73.10 /

+4.5 (+6.56%)

, HOOD

Robinhood

$48.31 /

-1.04 (-2.11%)

, OKTA

Okta

$259.60 /

+11.74 (+4.74%)

, DKS

Dick's Sporting

$132.24 /

+17.92 (+15.68%)

, TOL

Toll Brothers

$63.14 /

+1.93 (+3.15%)

, EXPR

Express

$6.44 /

-0.83 (-11.42%)

, URBN

Urban Outfitters

$37.34 /

-3.34 (-8.21%)

, JWN

Nordstrom

$31.64 /

-6.22 (-16.43%)

Get caught up quickly on…

ShowHide Related Items >><<
URBN Urban Outfitters
$37.34 /

-3.34 (-8.21%)

TSM TSMC
$118.14 /

+6.03 (+5.38%)

TOL Toll Brothers
$63.14 /

+1.93 (+3.15%)

TBPH Theravance Biopharma
$8.49 /

-0.73 (-7.92%)

SAVA Cassava Sciences
$89.11 /

-28.51 (-24.24%)

PBTS Powerbridge
$1.39 /

-0.005 (-0.36%)

OKTA Okta
$259.60 /

+11.74 (+4.74%)

NVAX Novavax
$240.57 /

+7.425 (+3.18%)

MRNA Moderna
$401.40 /

+6.44 (+1.63%)

MDT Medtronic
$134.55 /

+1.93 (+1.46%)

KSS Kohl's
$60.17 /

-0.02 (-0.03%)

JWN Nordstrom
$31.64 /

-6.22 (-16.43%)

JNJ Johnson & Johnson
$174.47 /

-0.88 (-0.50%)

HOOD Robinhood
$48.31 /

-1.04 (-2.11%)

GS Goldman Sachs
$416.31 /

+7.75 (+1.90%)

EXPR Express
$6.44 /

-0.83 (-11.42%)

DKS Dick's Sporting
$132.24 /

+17.92 (+15.68%)

DDAIF Daimler AG
$83.20 /

+1.065 (+1.30%)

DAL Delta Air Lines
$41.39 /

+0.87 (+2.15%)

CPB Campbell Soup
$41.05 /

-0.98 (-2.33%)

BYND Beyond Meat
$121.25 /

-2.88 (-2.32%)

ARGGY Aston Martin Lagonda
$27.35 /

+0.7 (+2.63%)

APO Apollo Global
$58.55 /

+0.915 (+1.59%)

AMZN Amazon.com
$3,292.98 /

-14.14 (-0.43%)

AMCX AMC Networks
$47.88 /

-0.63 (-1.30%)

AFRM Affirm
$73.10 /

+4.5 (+6.56%)

JNJ Johnson & Johnson
$174.47 /

-0.88 (-0.50%)

08/20/21 Morgan Stanley
J&J CEO change 'a surprise,' but not due to business issues, says Morgan Stanley
08/05/21 SVB Leerink
Protagonist Therapeutics price target raised to $50 from $41 at SVB Leerink
08/03/21 Piper Sandler
Arcturus strength attributable to large pharma's interest in mRNA, says Piper
07/29/21 Benchmark
Emergent BioSolutions' catalysts 'falling into place,' says Benchmark
SAVA Cassava Sciences
$89.11 /

-28.51 (-24.24%)

08/25/21 JonesTrading
Cassava addressed most key concerns in lawyer report, says JonesTrading
08/03/21 B. Riley
Cassava Sciences price target raised to $145 from $111 at B. Riley
07/30/21 B. Riley
Cassava Sciences data represents 'home run scenario,' says B. Riley
07/20/21 H.C. Wainwright
Cassava Sciences price target raised to $124 from $97 at H.C. Wainwright
PBTS Powerbridge
$1.39 /

-0.005 (-0.36%)

AMCX AMC Networks
$47.88 /

-0.63 (-1.30%)

07/22/21 Deutsche Bank
AMC Networks downgraded to Sell from Hold at Deutsche Bank
05/14/21 Goldman Sachs
AMC Networks upgraded to Neutral from Sell at Goldman Sachs
05/10/21 Wells Fargo
AMC Networks price target lowered to $45 from $52 at Wells Fargo
03/26/21 Wells Fargo
AMC Networks downgraded to Underweight from Equal Weight at Wells Fargo
DAL Delta Air Lines
$41.39 /

+0.87 (+2.15%)

08/11/21 Redburn
Delta Air Lines initiated with a Neutral at Redburn
07/15/21 Morgan Stanley
Delta shares deserve to be trading 'significantly higher,' says Morgan Stanley
07/15/21
Fly Intel: Top five analyst upgrades
07/15/21 Susquehanna
Delta Air Lines price target lowered to $45 from $53 at Susquehanna
TBPH Theravance Biopharma
$8.49 /

-0.73 (-7.92%)

08/24/21 Morgan Stanley
Morgan Stanley cuts Theravance Biopharma to Underweight after failed UC study
08/24/21 Morgan Stanley
Theravance downgraded to Underweight from Overweight at Morgan Stanley
08/24/21
Fly Intel: Top five analyst downgrades
08/24/21 SVB Leerink
Theravance Biopharma price target lowered to $29 from $37 at SVB Leerink
MDT Medtronic
$134.55 /

+1.93 (+1.46%)

08/25/21 Truist
Medtronic price target raised to $148 from $138 at Truist
08/25/21 Credit Suisse
Medtronic price target raised to $146 from $137 at Credit Suisse
08/25/21 Wells Fargo
Medtronic price target raised to $151 from $140 at Wells Fargo
08/25/21 Raymond James
Medtronic price target raised to $142 from $135 at Raymond James
BYND Beyond Meat
$121.25 /

-2.88 (-2.32%)

08/25/21
Fly Intel: Top five analyst downgrades
08/25/21 Argus
Beyond Meat downgraded to Hold at Argus on disappointing guidance
08/25/21 Argus
Beyond Meat downgraded to Hold from Buy at Argus
08/06/21 Piper Sandler
Beyond Meat spending will continue to weigh on margins, says Piper Sandler
RCII Rent-A-Center
$65.54 /

+0.54 (+0.83%)

08/25/21
Fly Intel: Top five analyst initiations
08/25/21 BofA
Rent-A-Center started with Buy at BofA on lease-to-own rollout opportunity
08/25/21 BofA
Rent-A-Center initiated with a Buy at BofA
08/12/21 Janney Montgomery Scott
Rent-A-Center upgraded to Buy from Neutral at Janney Montgomery Scott
CPB Campbell Soup
$41.05 /

-0.98 (-2.33%)

08/25/21 Piper Sandler
Piper Sandler downgrades Campbell Soup on rising commodity prices
08/24/21 Piper Sandler
Campbell Soup downgraded to Neutral from Overweight at Piper Sandler
08/24/21 Deutsche Bank
Campbell Soup price target raised to $50 from $47 at Deutsche Bank
GS Goldman Sachs
$416.31 /

+7.75 (+1.90%)

07/14/21 Oppenheimer
Goldman Sachs price target raised to $540 from $493 at Oppenheimer
07/14/21 Credit Suisse
Goldman Sachs price target raised to $425 from $420 at Credit Suisse
07/14/21 Mizuho
Affirm selloff on Apple competition fears overblown, says Mizuho
07/14/21 Piper Sandler
Goldman Sachs price target raised to $435 from $420 at Piper Sandler
KSS Kohl's
$60.17 /

-0.02 (-0.03%)

08/20/21 Baird
Kohl's price target raised to $70 from $68 at Baird
08/20/21 Deutsche Bank
Kohl's price target raised to $80 from $73 at Deutsche Bank
08/11/21 Deutsche Bank
Kohl's named Short-Term Catalyst Buy idea at Deutsche Bank
08/09/21 BofA
BofA sees Kohl's partnership with Sephora as key driver to boost sales, earnings
AMZN Amazon.com
$3,292.98 /

-14.14 (-0.43%)

08/12/21 Bernstein
Impact of Amazon Singapore credit card surcharge very small, says Bernstein
08/05/21 Morgan Stanley
Amazon continues toward competing with parcel incumbents, says Morgan Stanley
07/30/21 JPMorgan
Amazon.com price target lowered to $4,100 from $4,600 at JPMorgan
07/30/21 Cowen
Amazon.com price target lowered to $4400 from $4600 at Cowen
TSM TSMC
$118.14 /

+6.03 (+5.38%)

08/02/21 Needham
Silicon Motion price target raised to $115 from $100 at Needham
07/19/21 Morgan Stanley
Texas Instruments price target raised to $185 from $176 at Morgan Stanley
07/06/21 Citi
Intel outsourcing chips to TSMC will help gain back share, says Citi
06/30/21
Fly Intel: Top five analyst upgrades
DDAIF Daimler AG
$83.20 /

+1.065 (+1.30%)

08/11/21 Barclays
Daimler AG price target lowered to EUR 110 from EUR 115 at Barclays
08/09/21 Jefferies
Daimler AG downgraded to Hold from Buy at Jefferies
08/01/21 Goldman Sachs
Daimler AG upgraded to Conviction Buy from Buy at Goldman Sachs
07/23/21 Kepler Cheuvreux
Daimler AG upgraded to Buy at Kepler Cheuvreux following pullback
ARGGY Aston Martin Lagonda
$27.35 /

+0.7 (+2.63%)

08/02/21 JPMorgan
Aston Martin Lagonda price target raised to 1,700 GBp at JPMorgan
07/07/21 JPMorgan
Aston Martin Lagonda price target raised to 1,430 GBp at JPMorgan
05/11/21 Goldman Sachs
Aston Martin Lagonda upgraded to Neutral from Sell at Goldman Sachs
03/23/21 Kepler Cheuvreux
Autos upgraded to Overweight from Neutral at Kepler Cheuvreux
APO Apollo Global
$58.55 /

+0.915 (+1.59%)

08/05/21 Oppenheimer
Apollo Global price target raised to $67 from $62 at Oppenheimer
08/03/21 Morgan Stanley
Apollo Global, Nasdaq named Diversified Financials Top Picks at Morgan Stanley
07/15/21 Morgan Stanley
Athene Holding downgraded to Equal Weight from Overweight at Morgan Stanley
07/12/21 Citi
Apollo Global price target raised to $76 from $72 at Citi
NVAX Novavax
$240.57 /

+7.425 (+3.18%)

08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
MRNA Moderna
$401.40 /

+6.44 (+1.63%)

08/12/21 Wells Fargo
Wells says Moderna vaccine looks more effective than Pfizer's against Delta
08/06/21
Fly Intel: Top five analyst downgrades
08/06/21 Oppenheimer
Moderna downgraded to Perform from Outperform at Oppenheimer
08/06/21 Piper Sandler
Moderna downgraded to Neutral from Overweight at Piper Sandler
AFRM Affirm
$73.10 /

+4.5 (+6.56%)

08/25/21 BofA
Affirm price target raised to $82 from $71 at BofA
08/23/21 Oppenheimer
Peloton price target lowered to $140 from $150 at Oppenheimer
08/18/21 Truist
Truist starts Marqeta at Buy on next-gen vCard solutions success
08/03/21 DA Davidson
Affirm downgraded to Neutral from Buy at DA Davidson
HOOD Robinhood
$48.31 /

-1.04 (-2.11%)

08/23/21
Fly Intel: Top five analyst initiations
08/23/21 Rosenblatt
Robinhood initiated with a Buy at Rosenblatt
08/23/21 JPMorgan
JPMorgan starts Robinhood at Underweight, says success priced into shares
08/23/21 Deutsche Bank
Deutsche starts Robinhood at Hold despite 'exceptionally attractive' potential
OKTA Okta
$259.60 /

+11.74 (+4.74%)

08/25/21
Fly Intel: Top five analyst upgrades
08/25/21 Raymond James
Okta upgraded to Strong Buy from Outperform at Raymond James
08/25/21 Raymond James
Okta upgraded to Strong Buy from Outperform at Raymond James
08/06/21 Wolfe Research
Okta initiated with an Outperform at Wolfe Research
DKS Dick's Sporting
$132.24 /

+17.92 (+15.68%)

08/20/21 Cowen
Dick's Sporting price target raised to $150 from $147 at Cowen
08/18/21 Wedbush
Dick's Sporting price target raised to $125 from $110 at Wedbush
08/11/21
Fly Intel: Top five analyst initiations
08/11/21 Wells Fargo
Dick's Sporting resumed with an Equal Weight at Wells Fargo
TOL Toll Brothers
$63.14 /

+1.93 (+3.15%)

06/30/21 Goldman Sachs
Toll Brothers price target lowered to $55 from $59 at Goldman Sachs
06/28/21 BTIG
Toll Brothers upgraded to Neutral from Sell at BTIG
05/27/21 BTIG
Toll Brothers price target raised to $59 from $49 at BTIG
05/27/21 Barclays
Toll Brothers price target raised to $62 from $53 at Barclays
EXPR Express
$6.44 /

-0.83 (-11.42%)

06/04/21 B. Riley
Express price target raised to $4.50 from $3.50 at B. Riley
03/11/21 B. Riley
Express price target raised to $3.50 from $1.50 at B. Riley Securities
01/15/21 B. Riley
Express price target raised to $1.50 from $1 at B. Riley Securities
URBN Urban Outfitters
$37.34 /

-3.34 (-8.21%)

08/25/21 BMO Capital
Urban Outfitters price target raised to $37 from $35 at BMO Capital
08/25/21 MKM Partners
Urban Outfitters price target raised to $43 from $41 at MKM Partners
08/25/21 Wells Fargo
Urban Outfitters price target raised to $40 from $35 at Wells Fargo
08/25/21 Deutsche Bank
Urban Outfitters price target raised to $42 from $40 at Deutsche Bank
JWN Nordstrom
$31.64 /

-6.22 (-16.43%)

08/25/21 Credit Suisse
Nordstrom price target lowered to $34 from $39 at Credit Suisse
08/25/21 JPMorgan
JPMorgan downgrades Nordstrom to sell on 'underwhelming' performance
08/25/21 JPMorgan
Nordstrom downgraded to Underweight from Neutral at JPMorgan
08/25/21 Deutsche Bank
Nordstrom price target lowered to $37 from $40 at Deutsche Bank
URBN Urban Outfitters
$37.34 /

-3.34 (-8.21%)

TSM TSMC
$118.14 /

+6.03 (+5.38%)

TOL Toll Brothers
$63.14 /

+1.93 (+3.15%)

TBPH Theravance Biopharma
$8.49 /

-0.73 (-7.92%)

SAVA Cassava Sciences
$89.11 /

-28.51 (-24.24%)

RCII Rent-A-Center
$65.54 /

+0.54 (+0.83%)

OKTA Okta
$259.60 /

+11.74 (+4.74%)

NVAX Novavax
$240.57 /

+7.425 (+3.18%)

MRNA Moderna
$401.40 /

+6.44 (+1.63%)

MDT Medtronic
$134.55 /

+1.93 (+1.46%)

KSS Kohl's
$60.17 /

-0.02 (-0.03%)

JWN Nordstrom
$31.64 /

-6.22 (-16.43%)

JNJ Johnson & Johnson
$174.47 /

-0.88 (-0.50%)

HOOD Robinhood
$48.31 /

-1.04 (-2.11%)

GS Goldman Sachs
$416.31 /

+7.75 (+1.90%)

EXPR Express
$6.44 /

-0.83 (-11.42%)

DKS Dick's Sporting
$132.24 /

+17.92 (+15.68%)

DDAIF Daimler AG
$83.20 /

+1.065 (+1.30%)

DAL Delta Air Lines
$41.39 /

+0.87 (+2.15%)

CPB Campbell Soup
$41.05 /

-0.98 (-2.33%)

BYND Beyond Meat
$121.25 /

-2.88 (-2.32%)

APO Apollo Global
$58.55 /

+0.915 (+1.59%)

AMZN Amazon.com
$3,292.98 /

-14.14 (-0.43%)

AMCX AMC Networks
$47.88 /

-0.63 (-1.30%)

AFRM Affirm
$73.10 /

+4.5 (+6.56%)

  • 29
    Jul
  • 25
    Jun
  • 13
    Jan
  • 13
    Nov
TSM TSMC
$118.14 /

+6.03 (+5.38%)

TOL Toll Brothers
$63.14 /

+1.93 (+3.15%)

SAVA Cassava Sciences
$89.11 /

-28.51 (-24.24%)

OKTA Okta
$259.60 /

+11.74 (+4.74%)

NVAX Novavax
$240.57 /

+7.425 (+3.18%)

MRNA Moderna
$401.40 /

+6.44 (+1.63%)

MDT Medtronic
$134.55 /

+1.93 (+1.46%)

KSS Kohl's
$60.17 /

-0.02 (-0.03%)

JNJ Johnson & Johnson
$174.47 /

-0.88 (-0.50%)

HOOD Robinhood
$48.31 /

-1.04 (-2.11%)

GS Goldman Sachs
$416.31 /

+7.75 (+1.90%)

EXPR Express
$6.44 /

-0.83 (-11.42%)

DDAIF Daimler AG
$83.20 /

+1.065 (+1.30%)

DAL Delta Air Lines
$41.39 /

+0.87 (+2.15%)

CPB Campbell Soup
$41.05 /

-0.98 (-2.33%)

BYND Beyond Meat
$121.25 /

-2.88 (-2.32%)

ARGGY Aston Martin Lagonda
$27.35 /

+0.7 (+2.63%)

APO Apollo Global
$58.55 /

+0.915 (+1.59%)

AMZN Amazon.com
$3,292.98 /

-14.14 (-0.43%)

AMCX AMC Networks
$47.88 /

-0.63 (-1.30%)

AFRM Affirm
$73.10 /

+4.5 (+6.56%)

TSM TSMC
$118.14 /

+6.03 (+5.38%)

TOL Toll Brothers
$63.14 /

+1.93 (+3.15%)

TBPH Theravance Biopharma
$8.49 /

-0.73 (-7.92%)

SAVA Cassava Sciences
$89.11 /

-28.51 (-24.24%)

RCII Rent-A-Center
$65.54 /

+0.54 (+0.83%)

PBTS Powerbridge
$1.39 /

-0.005 (-0.36%)

OKTA Okta
$259.60 /

+11.74 (+4.74%)

MRNA Moderna
$401.40 /

+6.44 (+1.63%)

MDT Medtronic
$134.55 /

+1.93 (+1.46%)

KSS Kohl's
$60.17 /

-0.02 (-0.03%)

JNJ Johnson & Johnson
$174.47 /

-0.88 (-0.50%)

HOOD Robinhood
$48.31 /

-1.04 (-2.11%)

GS Goldman Sachs
$416.31 /

+7.75 (+1.90%)

EXPR Express
$6.44 /

-0.83 (-11.42%)

DKS Dick's Sporting
$132.24 /

+17.92 (+15.68%)

DDAIF Daimler AG
$83.20 /

+1.065 (+1.30%)

DAL Delta Air Lines
$41.39 /

+0.87 (+2.15%)

CPB Campbell Soup
$41.05 /

-0.98 (-2.33%)

BYND Beyond Meat
$121.25 /

-2.88 (-2.32%)

APO Apollo Global
$58.55 /

+0.915 (+1.59%)

AMZN Amazon.com
$3,292.98 /

-14.14 (-0.43%)

AMCX AMC Networks
$47.88 /

-0.63 (-1.30%)

AFRM Affirm
$73.10 /

+4.5 (+6.56%)

URBN Urban Outfitters
$37.34 /

-3.34 (-8.21%)

TSM TSMC
$118.14 /

+6.03 (+5.38%)

TOL Toll Brothers
$63.14 /

+1.93 (+3.15%)

SAVA Cassava Sciences
$89.11 /

-28.51 (-24.24%)

OKTA Okta
$259.60 /

+11.74 (+4.74%)

NVAX Novavax
$240.57 /

+7.425 (+3.18%)

MRNA Moderna
$401.40 /

+6.44 (+1.63%)

MDT Medtronic
$134.55 /

+1.93 (+1.46%)

KSS Kohl's
$60.17 /

-0.02 (-0.03%)

JWN Nordstrom
$31.64 /

-6.22 (-16.43%)

JNJ Johnson & Johnson
$174.47 /

-0.88 (-0.50%)

HOOD Robinhood
$48.31 /

-1.04 (-2.11%)

GS Goldman Sachs
$416.31 /

+7.75 (+1.90%)

EXPR Express
$6.44 /

-0.83 (-11.42%)

DKS Dick's Sporting
$132.24 /

+17.92 (+15.68%)

DAL Delta Air Lines
$41.39 /

+0.87 (+2.15%)

CPB Campbell Soup
$41.05 /

-0.98 (-2.33%)

BYND Beyond Meat
$121.25 /

-2.88 (-2.32%)

APO Apollo Global
$58.55 /

+0.915 (+1.59%)

AMZN Amazon.com
$3,292.98 /

-14.14 (-0.43%)

AFRM Affirm
$73.10 /

+4.5 (+6.56%)

Hot Stocks
Novavax to participate in OCTAVE-DUO study » 09:28
08/25/21
08/25
09:28
08/25/21
09:28
NVAX

Novavax

$233.13 /

-17.87 (-7.12%)

Novavax announced that…

Novavax announced that Novavax' recombinant nanoparticle protein vaccine candidate is being studied in OCTAVE-DUO, now underway in the UK to evaluate the safety and immunogenicity of a third COVID-19 vaccine dose in participants with impaired immune systems. Funded by the UK government's Vaccines Taskforce and the UK Research and Innovation, the study is being led by the University of Glasgow and University of Birmingham. It is a follow-on to OCTAVE, which evaluated the immune response to COVID-19 vaccines in participants with impaired immune systems due to cancer, inflammatory arthritis, kidney or liver diseases, or a stem cell transplant. As part of OCTAVE-DUO, 320 participants with lymphoid malignancies from OCTAVE and similar studies who demonstrated low or no response to two doses of a primary COVID-19 vaccine regimen will be randomly assigned to receive a third vaccine dose from one of three manufacturers at least 14 days after completing the initial 2-dose regime. The individuals may receive the same vaccine as the first two doses or one from another manufacturer. Of these participants, one third will be administered Novavax' recombinant nanoparticle protein-based COVID-19 vaccine, NVX-CoV2373. Participants will be evaluated for changes in vaccine-specific immune responses and any adverse events, with findings expected later in 2021.

ShowHide Related Items >><<
NVAX Novavax
$233.13 /

-17.87 (-7.12%)

NVAX Novavax
$233.13 /

-17.87 (-7.12%)

08/04/21 Cantor Fitzgerald
Novavax EU deal suggests bottlenecks have been resolved, says Cantor Fitzgerald
06/15/21 Cantor Fitzgerald
Novavax price target raised to $272 from $217 at Cantor Fitzgerald
06/07/21 B. Riley
Novavax risk/reward attractive into Covid vaccine data, says B. Riley
05/12/21
Fly Intel: Top five analyst downgrades
NVAX Novavax
$233.13 /

-17.87 (-7.12%)

NVAX Novavax
$233.13 /

-17.87 (-7.12%)

NVAX Novavax
$233.13 /

-17.87 (-7.12%)

NVAX Novavax
$233.13 /

-17.87 (-7.12%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.